The International AIDS Vaccine Initiative (IAVI) has called for a doubling of donor commitments to HIV vaccine research, to at least US $1.2 billion annually, Reuters reported.
"The whole system for vaccines is not aligned properly - we have to find better ways to accelerate research, finance research and to create incentives for pharmaceutical companies," IAVI president Seth Berkley said during the recent World Economic Forum annual meeting in Davos, Switzerland.
Berkley noted that although the Group of Eight industrialised nations had expressed support for making HIV vaccine research a priority at six different meetings - including the 2005 gathering in Gleneagles, Scotland - implementation of these promises remained an important obligation.
IAVI warned that the potential bird flu epidemic was highlighting the problems that resulted from not taking a long-term approach to vaccine development.
This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions
Right now, we’re working with contributors on the ground in Ukraine and in neighbouring countries to tell the stories of people enduring and responding to a rapidly evolving humanitarian crisis.
We’re documenting the threats to humanitarian response in the country and providing a platform for those bearing the brunt of the invasion. Our goal is to bring you the truth at a time when disinformation is rampant.
But while much of the world’s focus may be on Ukraine, we are continuing our reporting on myriad other humanitarian disasters – from Haiti to the Sahel to Afghanistan to Myanmar. We’ve been covering humanitarian crises for more than 25 years, and our journalism has always been free, accessible for all, and – most importantly – balanced.
You can support our journalism from just $5 a month, and every contribution will go towards our mission.